Celgene Corp (Celgene), a subsidiary of Bristol-Myers Squibb Co, is an integrated biopharmaceutical company that discovers, develops, manufactures, and markets novel gene and protein regulation therapies for the treatment of cancer and immune-inflammatory diseases. Its major product portfolio includes Revlimid (lenalidomide), Pomalyst (pomalidomide) and Thalomid (thalidomide) for the treatment of multiple myeloma; and Abraxane (paclitaxel albumin-bound particles for injectable suspension) for various types of cancers, among others. The company sells its products through own sales organizations and distributors in Europe, the Americas, the Middle-East and Asia-Pacific. Celgene is headquartered in Summit, New Jersey, the US.

Headquarters United States of America

Address 86 Morris Avenue, Summit, New Jersey, 07901


Telephone 1 800 3844907

Industry Pharmaceuticals and Healthcare

   

Access premium data and analytics for Celgene Corp

1,300+

Clinical Trials

Determine Celgene Corp go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

500+

Catalyst Calendar

Proactively evaluate Celgene Corp’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

420+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

310+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Celgene Corp’s relevant decision makers and contact details.

250+

Pipeline Drugs

Identify which of Celgene Corp’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

50+

Marketed Drugs

Understand Celgene Corp’s commercialized product portfolio to stay one step ahead of the market.

15+

Sales & Consensus Forecasts

Understand the current and future drug revenue for Celgene Corp and assess market opportunity for new entrants with patient population 8-year forecasts.

230+

Install Base

Install Base provides a holistic and a granular view of the IT product/service deployments from leading vendors. Explore IT infrastructure categories, solution and product/service areas deployed by a prospect.

10+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

1

Medical Marketed Products

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Celgene Corp’s likely spend across technology areas enabling you to understand the digital strategy.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Brands
Marketed Abraxane
Paclitaxel Protein-Bound Particles For Injectable Suspension (Albumin-Bound) Istodax
Romidespsin Otezla
XXX XXX
XXX XXX
XXX XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More
Image for loader

Competitor Comparison

Key Parameters Celgene Corp Johnson & Johnson Novartis AG Merck & Co Inc Sanofi
Headquarters United States of America United States of America Switzerland United States of America France
City Summit New Brunswick Basel Kenilworth Paris
State/Province New Jersey New Jersey - New Jersey -
No. of Employees - 141,700 108,000 68,000 95,442
Entity Type Private Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Executives
Name Position Board Since Age
Steven Flostrand Senior Director- Value, Access and Pricing Execution Senior Management - -
Edward Kiruluta Senior Director- Informatics Systems Senior Management - -
Non Dignissim Eros Proin vel Convallis 2023 XX
Non Dignissim Eros Proin vel Convallis 2023 XX
Non Dignissim Eros Proin vel Convallis 2023 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company Analytics

Contact the team or request a demo to find out how our data can drive your business forward

Why are you leaving?